TipRanks

Erik Holmlin Insider Profile

4 Followers
Erik Holmlin, President & CEO, Director at BioNano Genomics, holds 1.66K shares in BioNano Genomics (Ticker: BNGO), holds 1.63K shares in Bionano Genomics Inc (Ticker: BNGOU), holds 0.00 shares in Nanosphere (Ticker: NSPH).
tipranks
Erik Holmlin

Erik Holmlin
BioNano Genomics (BNGO)
President & CEO, Director

Ranked #94,753 out of 109,030 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-64.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3K
100.00%
A breakdown of Erik Holmlin's holdings

Insider Roles

BioNano Genomics
(BNGO)
President & CEO, Director
Roles that Erik Holmlin holds in companies

Most Profitable Insider Trade

Stock:
BioNano Genomics
(BNGO)
Rating:Informative Buy
Date:Dec 01, 2021 - Dec 01, 2022
Return:-46.40%
The most profitable trade made by Erik Holmlin

Erik Holmlin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioNano Genomics
Feb 18, 2026
President & CEO, Director
Uninformative Sell
56.10
$2.87K
NSPH
Nanosphere
Jul 01, 2016
Uninformative Sell
17.00K
$0.00
BNGOU
Bionano Genomics Inc
Aug 27, 2018
Informative Buy
9.98K
$12.31K
List of latest transactions for each holding click on a transaction to see Erik Holmlin's performance on stock

Erik Holmlin insider profile FAQ

What is the percentage of profitable transactions made by Erik Holmlin?
The percentage of profitable transactions made by Erik Holmlin is 0%.
    What is the average return per transaction made by Erik Holmlin?
    The average return per transaction made by Erik Holmlin is -64.70%.
      What stocks does Erik Holmlin hold?
      Erik Holmlin holds: BNGO, NSPH, BNGOU stocks.
        What was Erik Holmlin’s latest transaction?
        Erik Holmlin latest transaction was an Uninformative Sell of $56.10.
          What was Erik Holmlin's most profitable transaction?
          Erik Holmlin’s most profitable transaction was an Informative Buy of BNGO stock on December 1, 2021. The return on the trade was -46.40%.
            What is Erik Holmlin's role in BioNano Genomics?
            Erik Holmlin's role in BioNano Genomics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.